Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?


OverviewForecastRevenueFinancialsChartTranscripts

Ocular Therapeutix Ownership Summary


Ocular Therapeutix is owned by 17.69% institutional investors, 2.60% insiders, and 79.70% retail investors. Fmr is the largest institutional shareholder, holding 18.42% of OCUL shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.99% of its assets in Ocular Therapeutix shares.

OCUL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOcular Therapeutix17.69%2.60%79.70%
SectorHealthcare Stocks 42.03%10.80%47.17%
IndustryBiotech Stocks 44.27%10.76%44.97%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr31.79M18.42%$371.57M
Blackrock11.52M8.73%$78.80M
Vr adviser13.16M7.63%$153.86M
Summer road12.58M7.29%$147.05M
Deep track capital, lp11.93M6.91%$139.49M
Blackrock funding, inc. /de10.56M6.12%$123.41M
Avoro capital advisors10.25M5.94%$119.82M
Vanguard group9.16M5.31%$107.12M
Tcg crossover management6.12M3.54%$71.51M
Point72 asset management4.60M2.67%$53.79M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Summer road12.58M98.57%$147.05M
Acuta capital partners1.17M14.08%$13.62M
Vr adviser13.16M8.66%$153.86M
Deltec asset management2.76M5.33%$32.29M
Octagon capital advisors lp2.62M4.65%$30.67M
Deep track capital, lp11.93M3.89%$139.49M
Harbert fund advisors50.00K3.81%$584.50K
Knoll capital management600.40K3.76%$7.02M
Tcg crossover management6.12M3.52%$71.51M
Logos global management lp3.25M3.41%$37.99M

Top Buyers

HolderShares% AssetsChange
Fmr31.79M0.02%12.18M
Blackrock11.52M0.00%3.46M
Alliancebernstein3.42M0.01%3.26M
Avoro capital advisors10.25M1.55%2.85M
Point72 asset management4.60M0.09%2.70M

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp11.93M3.89%-2.36M
Braidwell lp---2.24M
Great point partners---1.73M
Summer road12.58M98.57%-1.31M
Franklin resources---1.17M

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp1.60M0.02%1.60M$18.72M
Eventide asset management598.00K0.11%598.00K$6.99M
Driehaus capital management518.75K0.04%518.75K$6.06M
Axa investment managers439.88K0.01%439.88K$5.14M
Hrt financial lp322.91K0.01%322.91K$3.77M

Sold Out

HolderChange
Parallel advisors-1.00
Financial gravity asset management-1.00
Federated hermes-2.00
Twin peaks wealth advisors-2.00
Nelson, van denburg & campbell wealth management group-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202570-63.92%30,539,013-80.55%170.21%28-71.43%23-51.06%
Jun 30, 2025192-4.48%156,898,61016.16%901.43%963.23%47-20.34%
Mar 31, 20252028.60%137,366,9062.63%811.26%93-1.06%6057.89%
Dec 31, 20241772.31%128,615,765-8.11%771.10%8914.10%36-21.74%
Sep 30, 202417213.91%139,954,0592.07%830.78%79-13.19%4670.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S8.69M4.99%1.23M
Fidelity Growth Company Fund6.71M3.86%707.14K
Vanguard US Total Market Shares ETF4.64M2.92%-
Vanguard Total Stock Mkt Idx Inv4.70M2.72%-104.94K
iShares Russell 2000 ETF3.39M1.95%-
Fidelity Growth Company K61.82M1.05%381.23K
Fidelity Series Growth Company1.78M1.02%232.30K
Fidelity Small Cap Index1.41M0.81%-191.43K
Vanguard Institutional Extnd Mkt Idx Tr1.38M0.80%-593.25K
Fidelity Select Pharmaceuticals Port1.31M0.75%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 05, 2025Saroj Namrata Chief Business OfficerSell$277.79K
Oct 08, 2025Anderman Todd Chief Legal OfficerSell$137.37K
Oct 02, 2025Kaiser Peter Chief Development OfficerSell$106.47K
Oct 02, 2025Heier Jeffrey S. Chief Scientific OfficerSell$115.94K
Sep 02, 2025Notman Donald See RemarksSell$13.25K

Insider Transactions Trends


DateBuySell
2025 Q4-4
2025 Q3-5
2025 Q215
2025 Q1-6
2024 Q4-4

OCUL Ownership FAQ


Who Owns Ocular Therapeutix?

Ocular Therapeutix shareholders are primarily institutional investors at 17.69%, followed by 2.60% insiders and 79.71% retail investors. The average institutional ownership in Ocular Therapeutix's industry, Biotech Stocks , is 44.27%, which Ocular Therapeutix falls below.

Who owns the most shares of Ocular Therapeutix?

Ocular Therapeutix’s largest shareholders are Fmr (31.79M shares, 18.42%), Blackrock (11.52M shares, 8.73%), and Vr adviser (13.16M shares, 7.63%). Together, they hold 34.77% of Ocular Therapeutix’s total shares outstanding.

Does Blackrock own Ocular Therapeutix?

Yes, BlackRock owns 8.73% of Ocular Therapeutix, totaling 11.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 78.8M$. In the last quarter, BlackRock increased its holdings by 3.46M shares, a 42.87% change.

Who is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested?

Summer road is Ocular Therapeutix’s biggest shareholder by percentage of total assets invested, with 98.57% of its assets in 12.58M Ocular Therapeutix shares, valued at 147.05M$.

Who is the top mutual fund holder of Ocular Therapeutix shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Ocular Therapeutix shares, with 4.99% of its total shares outstanding invested in 8.69M Ocular Therapeutix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools